NightWare

FDA grants De Novo clearance to prescription Apple Watch app for nightmare disorder
By Dave Muoio | 03:47 pm | November 09, 2020
NightWare's digital therapeutic monitors a wearer's heart rate and movement to detect disturbances during sleep, and delivers gentle vibrations to interrupt a nightmare without waking the user.
Apple Watch app for nightmare disorder receives FDA breakthrough designation, opens enrollment for two RCTs
By Dave Muoio | 04:48 pm | May 21, 2019
To see light as a prescription digital therapeutic for PTSD patients affected by nightmares, NightWare is testing its app among veterans and the general public.